4//SEC Filing
Kenney Richard T 4
Accession 0000905718-21-000515
CIK 0001106838other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 4:32 PM ET
Size
5.2 KB
Accession
0000905718-21-000515
Insider Transaction Report
Form 4
Kenney Richard T
Chief Medical Officer
Transactions
- Award
Common Stock
2021-03-25+25,000→ 25,000 total
Footnotes (1)
- [F1]On March 25, 2021, the Reporting Person was granted 25,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 50% of the restricted stock units on March 25, 2022 and 50% of the restricted stock units on March 25, 2023.
Documents
Issuer
Sonnet BioTherapeutics Holdings, Inc.
CIK 0001106838
Entity typeother
Related Parties
1- filerCIK 0001606653
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 4:32 PM ET
- Size
- 5.2 KB